期刊文献+

1例应用健择治疗肺癌致双眼过敏反应的护理

原文传递
导出
摘要 患者男性,64岁,因“右上肺中低分化癌”为行诊治入院治疗。于2009年1月6日行第一次健择1600rag静脉输液化疗,化疗前15min给予地塞米松2mg静脉入壶,化疗过程顺利。化疗结束后约30min患者主诉眼部不适,睁眼费力。检查发现双眼球结膜严重混合充血,双眼睑水肿明显。考虑为双眼过敏反应,即刻给予异丙嗪25mg肌肉注射,双鼻导管吸氧2L/min,测血压130/70mmHg(1mmHg=0.133kPa),HR90次/min,SaO2 97%,密切观察患者病情变化。请眼科会诊,给予可乐必妥滴眼剂1滴,滴双眼,1次/h。6h后患者双眼结膜充血略有好转,不适症状缓解。2d后双眼结膜充血完全消失。
出处 《中华现代护理杂志》 2010年第2期227-227,共1页 Chinese Journal of Modern Nursing
  • 相关文献

参考文献5

二级参考文献14

  • 1王孟昭,李龙芸,钟巍,张力,李俊荣,王淑兰,张晓彤.健择(吉西他滨)联合顺铂治疗晚期非小细胞肺癌的疗效和不良反应[J].中国医院用药评价与分析,2004,4(6):361-363. 被引量:7
  • 2[1]Linskens RK, Golding RP, Van Groeningen CJ, ct al. Severe acute lung in jury induced by gemcitabine. Neth J Med 2000 Jun; 56(6): 232~235
  • 3[2]Takada M, Negoro S, Kudo S, et al. Activity of gemcitabine in non-small-cell lung cancer: results of the Japan gemcitabine group(A) phase Ⅱ study. Cancer Chemother Pharmacol 1998:, 4(3): 217~222
  • 4[1]Shord SS, Fancette SR, Gillenwater HH, et al. Gemcitabinepharmacokinetics and interaction with paclitaxel in patients withadvanced non- small- cell lung cancer[ J]. Cancer ChemotherPharmacol, 2003,51: 328.
  • 5[2]Highlights from the 10th World Conference on Lung CancerIR]. Vancouver, British Columbia, Canada, August 10 - 14,2003. In: Clin Lung Cancer, 2003,5 (3): 142.
  • 6[3]Bretti S, Manzin E, Loddo C, et al. Gemcitabine plus cisplatinin the treatment of patients with advanced non - small cell lungcancer, a phase II study[ J ]. Anticancer Res, 2002,22: 3 039.
  • 7[4]Migliorino MR, De Marinis F, Nelli F, et al. A 3 - weekschedule of gemcitabine plus cisplatin as induction chemot-herapy for stage [1I non - small cell lung cancer [ J ]. LungCancer, 2002,35:319.
  • 8[5]Jassem J, Krzakowski M, Roszkowski K, et al. A phase Iistudy of gemcitabine plus cisplatin in patients with advancednon- small cell lung cancer: clinical outcomes and quality oflife[J]. Lung Cancer, 2002,35:73.
  • 9[6]Thongprasert S, Chewaskulyong B, Pothirat C. Combination ofgemcitabine and cisplatin in advanced non - small cell lungcancer[ J]. J Med Assoc Thai, 2001,84:397.
  • 10[7]Kusaba H, Tamura T, Shimoyama T, et al. Phase I / II studyof 3 - week cycle cisplating - gemcitabine in advanced non -small cell lung cancer[J]. Jpn J Clin Oncol, 2002,32:43.

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部